- ►shouxi.net AM Shapiro, C Ricordi, BJ Hering, H … - New England Journal of Medicine, 2006 - content.nejm.org AM James Shapiro, MD, Ph.D., Camillo Ricordi, MD, Bernhard J. Hering, MD, Hugh
Auchincloss, MD, Robert Lindblad, MD, R. Paul Robertson, MD, Antonio Secchi, MD,
Mathias D. Brendel, MD, Thierry Berney, MD, Daniel C. Brennan, MD, Enrico ... Cited by 388 - Related articles - BL Direct - All 9 versions
- ►publichealth.ru [PDF] D Daneman - The Lancet, 2006 - Elsevier Type 1 diabetes accounts for only about 5–10% of all cases of diabetes;
however, its incidence continues to increase worldwide and it has serious
short-term and long-term implications. The disorder has a strong genetic ... Cited by 125 - Related articles - All 27 versions
- ►nih.gov T Nir, DA Melton, Y Dor - Journal of Clinical Investigation, 2007 - Am Soc Clin Investig The mechanisms that regulate pancreatic β cell mass are poorly understood.
While autoimmune and pharmacological destruction of insulin-producing β cells
is often irreversible, adult β cell mass does fluctuate in response to ... Cited by 99 - Related articles - BL Direct - All 8 versions
- ►sciencemag.org IC Rulifson, SK Karnik, PW Heiser, D ten … - Proceedings of the National Academy of Sciences, 2007 - National Acad Sciences There is widespread interest in defining factors and mechanisms that stimulate
proliferation of pancreatic islet cells. Wnt signaling is an important regulator
of organ growth and cell fates, and genes encoding Wnt-signaling factors ... Cited by 63 - Related articles - BL Direct - All 8 versions
- ►ecmaj.com KM Gillespie - Canadian Medical Association Journal, 2006 - ecmaj.com Type 1 diabetes results from the autoimmune destruction of insulin-producing ß
cells in the pancreas. Genetic and, as yet undefined, environmental factors act
together to precipitate the disease. The excess mortality associated with ... Cited by 60 - Related articles - BL Direct - All 13 versions
- ►diabetesjournals.org NV Evgenov, Z Medarova, J Pratt, P … - Diabetes, 2006 - Am Diabetes Assoc As islet transplantation becomes an acceptable clinical modality for restoring
normoglycemia in type 1 diabetic patients, there is a crucial need for
noninvasive assessment of the fate of the grafts. In spite of the success ... Cited by 48 - Related articles - BL Direct - All 5 versions
PM Campbell, PA Senior, A Salam, K … - American Journal of Transplantation, 2007 - ccmjournal.org The institutional review board approved the study protocol. Daily screening
identified consecutive patients with ALI who were ad- mitted to three ICUs
(medical, surgical, and mixed medical-surgical) in the two Mayo Clinic ... Cited by 43 - Related articles - BL Direct - All 4 versions
PA Senior, M Zeman, BW Paty, EA Ryan, AMJ … - American Journal of Transplantation, 2007 - interscience.wiley.com Tight glycemic control can reduce progression of diabetic nephropathy (DN) while
the histological changes may regress after pancreas transplantation. Clinical
islet transplantation (CIT) can restore euglycemia but the effects of CIT ... Cited by 42 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org N Zhang, D Su, S Qu, T Tse, R Bottino, AN … - Diabetes, 2006 - Am Diabetes Assoc Successful islet transplantation depends on the infusion of sufficiently large
quantities of islets, but only a fraction of transplanted islets can survive and
become engrafted, and yet the underlying mechanism remains unclear. In this ... Cited by 41 - Related articles - BL Direct - All 7 versions
S Merani, A Shapiro - Clinical Science, 2006 - submit.clinsci.org Abbreviations: BMI, body mass index; CD40L, CD40 ligand; CITR, Collaborative
Islet Transplant Registry; CTLA4, cytotoxic T-lymphocyte attenuator protein 4;
CMV, cytomegalovirus; DCCT, Diabetes Control and Complications Trial; DM, ... Cited by 40 - Related articles - Cached - BL Direct - All 12 versions
